Skip to main content

cost-effectiveness

Department
04/12/2017
JCP Editors
Many patients receive immunotherapy prescriptions for off-label treatment, potentially contributing to unnecessary health care expenditures.  ----- Related Content Cost-Effective Immunotherapy Treatments for...
Many patients receive immunotherapy prescriptions for off-label treatment, potentially contributing to unnecessary health care expenditures.  ----- Related Content Cost-Effective Immunotherapy Treatments for...
Many...
04/12/2017
Journal of Clinical Pathways
Quiz
01/12/2017
JCP Editors
Use of oral targeted therapies for patients with chronic lymphocytic leukemia (CLL) is projected to have which result?   A)      Improved...
Use of oral targeted therapies for patients with chronic lymphocytic leukemia (CLL) is projected to have which result?   A)      Improved...
Use of...
01/12/2017
Journal of Clinical Pathways
Research in Review
12/16/2016
JCP Editors
New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...
New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...
New...
12/16/2016
Journal of Clinical Pathways
Pharma Insights
04/11/2016
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
Manufacturers set prices for their products that best represent their value while providing the greatest financial return on investment. Thus, conventional wisdom would suggest that manufacturers set a higher price...
...
04/11/2016
Journal of Clinical Pathways